3D Bio-Tissues utilizes bioprinting techniques to create bio-equivalent tissues for clinical and cellular agriculture applications. This technology provides a sustainable alternative to conventional tissue production, meeting the demand for ethical and scalable solutions in the medical and agricultural sectors.
Funding
$656.9K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional methods of producing tissues for clinical and agricultural applications often rely on animal components, which raises ethical concerns and limits scalability. The demand for human tissues and sustainable alternatives in medicine, cosmetics, and food production is growing rapidly.
Solution
3D Bio-Tissues (3DBT) utilizes a proprietary tissue templating process to produce bio-equivalent tissues without animal components. This bio-inspired, bottom-up approach enables the creation of structured, functional, and scalable tissues for various applications. 3DBT's technology replicates the complex nano- and macro-scale organization of native tissues, resulting in engineered tissues with enhanced performance and functionality. The company's products include biosynthetic human corneas, cultivated meat, skin substitutes, and leather alternatives.
Target Audience
3DBT's primary customers include researchers, clinicians, and companies in the medical, cosmetic, and cultivated meat industries seeking ethical and scalable tissue engineering solutions.
Features
- Tissue templating: A bio-inspired engineering platform for creating structured tissues.
- Cell-based approach: Produces highly organized tissue structures at nano- and macro-scales.
- Native-like functionality: Engineered tissues with appropriate ECM arrangement for enhanced performance.
- Scalable production: Suitable for centralized manufacturing without animal components.
- Etsyl™: A proprietary lipopeptide that promotes cellular collagen production in human skin cells.
- Biosynthetic human cornea: A fully biosynthetic in-vitro medical device that replicates the structure and properties of the native human cornea.